Table 4 Human cancer associated lncRNAs (adapted from[4])

HOTAIR

2158 nt

12q13.13

breast

[7, 140]

MALAT1/α/NEAT2

7.5 kb

11q13.1

breast, lung, uterus, pancreas, colon, prostate, liver, osteosarcoma, neuroblastoma, cervix

[146–151]

HULC

500 nt

6p24.3

liver

[152, 153]

BC200

200 nt

2p21

breast, cervix, esophagus, lung, ovary, parotid, tongue

[154, 155]

H19

2.3 kb

11p15.5

bladder, lung, liver, breast, endometrial, cervix esophagus, ovary, prostate, colorectal

[156–159]

BIC/MIRHG155/MIRHG2

1.6 kb

21q11.2

B-cell lymphoma

[160]

PRNCR1

13 kb

8q24.2

prostate

[161]

LOC285194

2105 nt

3q13.31

osteosarcoma

[162]

PCGEM1

1643 nt

2 g32.2

prostate

[163–165]

UCA1/CUDR

1.4–2.7 kb

19p13.12

bladder, colon, cervix, lung, thyroid, liver, breast, esophagus, stomach

[166]

DD3/PCA3

0.6–4 kb

9q21.22

prostate

[167, 168]

anti-NOS2A

1.9 kb

17q23.2

brain

[169]

uc.73A

201 nt

2q22.3

colon

[170]

uc.338

590 nt

12q13.13

liver

[171]

ANRIL/p15AS/CDK2BAS

34.8 kb

9p21.3

prostate, leukemia

[172–175]

MEG3

1.6 kb

14q32.2

brain

[176–178]

GAS5/SNHG2

isoforms

1q25.1

breast

[101]

SRA-1/SRA

1965 nt

5q31.3

breast, uterus, ovary

[179, 180]

PTENP1

3.9 kb

9p13.3

prostate

[181, 182]

ncRAN

2186 nt 2087 nt

17q25.1

bladder, neuroblastoma

[183, 184]

LSINCT5

2.6 kb

5p15.33

breast, ovary

[185]